Changing the Future of Healthcare with the Early Detection of Cancer
Abcodia is a specialist company engaged in the discovery and verification of biomarkers for cancer screening. Our mission is to change the way that biomarkers are developed to allow the earlier diagnosis of cancer and in this way help people live longer and healthier lives.
For more information about biomarkers for the early detection of cancer and Abcodia's capability and expertise please download our presentation.
A unique serum bank
In 2001, the UKCTOCS trial began collecting serum samples from over 200,000 women volunteers; this serum bank now contains over 500,000 serum samples, including over 350,000 longitudinal samples. In addition to the serum, there is a comprehensive database of phenotypic, demographic and disease incidence for each volunteer.
Click here for more information about how the serum biobank was created and the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).
Get in touch
To find out more about what Abcodia can offer and collaboration opportunities,
please contact us
Abcodia's Cancer Initiatives
The early detection of cancer and effective screening have been shown to improve survival and reduce deaths. Abcodia has analysed the cohort of volunteers and serum samples in four key cancer areas. Click any initiative below for more details.
Open and collaborative
We passionately believe that the best outcomes are gained through collaboration. Abcodia is keen to work with commercial and non-commercial organisations alike. We have a flexible approach and business model that allows our collaborators to make use of this unique resource. More
Abcodia selected as one of the UK’S most innovative life science companies
Abcodia has been judged one of the UK’s most innovative life science companies in a UK Trade & Investment competition, winning the opportunity to showcase its innovative work to an international audience at the BIO 2013 Convention in Chicago later this month More
Abcodia appoints industry expert to accelerate the
commercialisation of its cancer screening programmes
Abcodia has appointed Olle Nilsson as its consultant to provide industry related expertise. Dr Nilsson was formerly Vice-President of Business Development and Chief Scientific Officer with Fujirebio Diagnostics, based in America and Sweden More